De Franciscis P, Mainini G, Messalli E M, Trotta C, Luisi A, Laudando E, Marino G, Della Puca G, Cerreto F V, Torella M
Department of Obstetrics, Gynaecology and Reproductive Sciences - Second University of Naples, Naples, Italy.
Clin Exp Obstet Gynecol. 2013;40(1):58-60.
To evaluate female sexual dysfunction in hypertensive postmenopausal women and the effects of antihypertensive therapy.
Female sexual dysfunction was assessed by the Female Sexual Function Index (FSFI) in three groups of postmenopausal patients: normotensive women (group A: 240 women), hypertensive women without therapy (group B: 220 women), hypertensive women on therapy (group C: 80 women).
The incidence of female sexual dysfunction was increased in group B compared to groups A and C. Healthy patients showed higher FSFI scores compared to hypertensive patients (groups B and C). Hypertensive-treated patients accounted for higher scores in all items compared to hypertensive patients without therapy.
Essential hypertension significantly affects female sexual function. Physicians should recognize and properly manage FSD in hypertensive women.
评估绝经后高血压女性的性功能障碍及降压治疗的效果。
采用女性性功能指数（FSFI）对三组绝经后患者的性功能障碍进行评估：血压正常女性（A组：240名女性）、未接受治疗的高血压女性（B组：220名女性）、接受治疗的高血压女性（C组：80名女性）。
与A组和C组相比，B组女性性功能障碍的发生率更高。健康患者的FSFI评分高于高血压患者（B组和C组）。与未接受治疗的高血压患者相比，接受治疗的高血压患者在所有项目中的得分更高。
原发性高血压显著影响女性性功能。医生应认识并妥善处理高血压女性的性功能障碍。
